Nuñez Rodrigo, Sanchez Jesus A, Berber Salvador, Loaiza Felipe, Nuñez Jose G, Arias Sergio, Almeida Eduardo
UMAE Hospital de Cardiología CMN Siglo XXI IMSS, Calle Gabriel Mancera 306 Departamento 16, Colonia Del Valle, Delegación Benito Juarez 03100, Ciudad de México.
UMAE Hospital de Cardiología CMN Siglo XXI IMSS, Calle Cuauhtemoc 330, Colonia Doctores, Delegación Cuauhtemoc, Ciudad de México.
Eur Heart J Case Rep. 2021 Feb 16;5(2):ytaa580. doi: 10.1093/ehjcr/ytaa580. eCollection 2021 Feb.
A thrombus in transit (TIT) is a life-threatening condition associated with pulmonary embolism (PE). While TIT was once considered a rare diagnosis, its emergence has risen in recent years mainly through advancement in medical technology. Rare cases of a thrombus in transit crossing a patent foramen ovale in the context of pulmonary embolism have been reported. The appropriate treatment of patients in this setting remains unclear.
We describe a 64-year-old man who presented with syncope to the emergency room secondary to acute pulmonary embolism. Initial transthoracic echocardiogram revealed a large intracardiac thrombus in transit across a patent foramen ovale, verified by transoesophageal echocardiogram. He underwent anticoagulation and urgent surgical thrombectomy with a favourable outcome.
Risk stratification of patient with acute PE is mandatory for determining the appropriate therapeutic management. Initial risk stratification is based on clinical symptoms and signs of haemodynamic instability which indicate a high risk or early death associated massive PE. Thrombolytic therapy is indicated in high-risk patients (Grade 1B), while anticoagulation alone is recommended for intermediate-high- to low-risk patients. Assessment for intracardiac thrombi in PE modifies the treatment strategy in case of a thrombus in transit.
移动性血栓(TIT)是一种与肺栓塞(PE)相关的危及生命的疾病。虽然TIT曾经被认为是一种罕见的诊断,但近年来其发生率有所上升,主要是由于医疗技术的进步。已有报道在肺栓塞情况下移动性血栓穿过卵圆孔未闭的罕见病例。在这种情况下对患者的适当治疗仍不清楚。
我们描述了一名64岁男性,因急性肺栓塞继发晕厥而到急诊室就诊。最初的经胸超声心动图显示一个大的心脏内移动性血栓穿过卵圆孔未闭,经食管超声心动图证实。他接受了抗凝治疗和紧急手术取栓,结果良好。
对急性PE患者进行风险分层对于确定适当的治疗管理是必不可少的。初始风险分层基于血流动力学不稳定的临床症状和体征,这表明与大面积PE相关的高风险或早期死亡。高危患者(1B级)适用溶栓治疗,而中高风险至低风险患者建议单独使用抗凝治疗。在PE中对心脏内血栓的评估会在出现移动性血栓的情况下改变治疗策略。